Physician profile
Andrew E Willson
NPI 1952770976
$11,833.94
in general payments reported to CMS, 2019-2025
47 companies · $2,777 in 2025
The $2,777 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,243 · 2022: $2,192 · 2023: $2,244 · 2024: $2,378 · 2025: $2,777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,399.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,309.07 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,220.14 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $1,148.60 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $912.98 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $581.73 | 2021-2025 | Repatha, Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $522.33 | 2021-2025 | |
| Pfizer INC. | $448.98 | 2021-2025 | |
| Glaxosmithkline, LLC. | $438.31 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $436.71 | 2021-2025 | |
| Abbott Laboratories | $394.92 | 2021-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $364.58 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Astellas Pharma US INC | $353.85 | 2021-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $344.47 | 2021-2024 | Trintellix |
| Janssen Pharmaceuticals, INC | $326.98 | 2021-2024 | Spravato |
| Vanda Pharmaceuticals INC. | $322.58 | 2025 | Fanapt, Hetlioz |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Willson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.